Placebo IV Clinical Trials
10 recruitingDrug
Phase 15Phase 34Phase 23
Showing 1–10 of 10 trials
Recruiting
Phase 2
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Spinal Muscular Atrophy (SMA)
argenx60 enrolled17 locationsNCT07287982
Recruiting
Phase 1Phase 2
Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia
Androgenetic alopecia (AGA)Healthy Volunteers - Male and Female
Absci Pty Ltd.227 enrolled4 locationsNCT07317544
Recruiting
Phase 1
Adia Med of Winter Park LLC Chronic Kidney Disease Research Study
Kidney Disease, ChronicChronic Kidney DiseaseKidney Disease+2 more
Adia Med of Winter Park LLC100 enrolled1 locationNCT07572890
Recruiting
Phase 1
Adia Med of Winter Park LLC Lower Back Pain Research Study
Lower back painChronic Lower Back PainChronic Mechanical Lower Back Pain
Adia Med of Winter Park LLC100 enrolled1 locationNCT07587047
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Chronic Inflammatory Demyelinating PolyneuropathyChronic Inflammatory Demyelinating PolyradiculoneuropathyCIDP
argenx160 enrolled43 locationsNCT07091630
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Primary Immune Thrombocytopenia (ITP)
argenx69 enrolled94 locationsNCT06544499
Recruiting
Phase 2Phase 3
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
Immune Thrombocytopenic PurpuraITPIdiopathic Thrombocytopenic Purpura+4 more
argenx24 enrolled8 locationsNCT07194850
Recruiting
Phase 1
A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Eli Lilly and Company124 enrolled1 locationNCT06945406
Recruiting
Phase 1
Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population
Healthy Volunteers
Gates Medical Research Institute123 enrolled2 locationsNCT06408857
Recruiting
Phase 3
Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study
Intrahepatic Cholangiocarcinoma
Shanghai Junshi Bioscience Co., Ltd.480 enrolled1 locationNCT05342194